Quick navigation A.K.A. Intake Synergies Conditions Functions Systems

What are Piracetam's other names?

• 2-Oxo-1-pyrrolidine
• Fezam
• Memotopril
• Pyracetam
• Pyrrolidone acetamide
• UCB6215

What is Piracetam's recommended dosage?

• Recommended daily intake: 1,2 - 4,8 g
• Recommended daily doses: 3

What supplements interact with Piracetam?

What can Piracetam help with?

Piracetam for Breath Holding Spells

3 studies Highly Positive Complete blood count, biochemical profile, and urine analysis taken before and after treatment revealed no change from beginning to end and no difference between the 2 groups. It is suggested that piracetam is a safe and effective drug, with an incidence of side effects no different from that of placebo, for the treatment of breath-holding spells. Highly Positive In conclusion, piracetam is a safe and effective drug for the treatment of breath-holding spells in children. Highly Positive Piracetam is an effective prophylactic treatment for severe BHS.

Piracetam for Mild Cognitive Impairment

5 studies Moderately Positive A total of 135 patients, 45 in each group, completed the study. Combined therapy was most effective in patients whose baseline performance on memory tests was lowest. The best results were observed with 4.8 g of piracetam, especially when training sessions began after 6 weeks of drug treatment. This result was confirmed by the global impression of the principal investigator. Moderately Positive Fifty Patients completed the investigation (25 piracetam, 25 placebo). There were no significant statistical differences between the two groups of patients on all measures utilized except for the Clinical Global Evaluation, where 52% of the patients on piracetam showed minimal improvement versus 25% of the placebo group (P less than 0.05). Moderately Positive The effect of piracetam therapy with different dosages was studied in a double blind trial against placebo on its effect in psychoorganic syndrome of old age. 78 patients (61 females, 17 males) on the average of 73.2 years, showed statistically significant differences between piracetam therapy at a dosage of 3 X 1600 mg per day und placebo after a six week peroral therapy while no statistically significant differences between piracetam therapy at a dosage of 3X800 mg per day and placebo were found. Moderately Positive The results of the meta-analysis demonstrate a difference between those individuals treated with piracetam and those given placebo, both as significant odds ratio and as a favourable number needed to treat. While there may be problems in meta-analyses and the interpretation of the statistical results, the results of this analysis provide compelling evidence for the global efficacy of piracetam in a diverse group of older subjects with cognitive impairment. Moderately Positive Thirty subjects completed the 1-year study. No improvement occurred in either group, but our results support the hypothesis that long-term administration of high doses of piracetam might slow the progression of cognitive deterioration in patients with AD. The most significant differences concerned the recall of pictures series and recent incident and remote memory. The drug was well-tolerated.

What is Piracetam used for?

What are Piracetam's effects on the body?